Coronavirus | Indian scientists divided over nod for Covaxin
Updated:
Updated:
While some say safety parameters are good, others have asked for efficacy data
Share Article
AAA
Medical staff busy in last minute revision for vaccination at jumbo COVID-19 vaccination centre at Bandra-Kurla complex in Mumbai on the eve of first phase vaccination drive. | Photo Credit: Vivek Bendre
While some say safety parameters are good, others have asked for efficacy data
While 3,000 sites across India prepare to vaccinate three crore high-risk individuals, beginning with healthcare workers, from January 16, scientists and doctors are divided on the issue of restricted use approval granted to the Hyderabad-based Bharat Biotech’s Covaxin, a COVID-19 vaccine.
India will treat a domestic Covid-19 vaccine "equally" with a prominent global one, even though the homegrown drug's efficacy has not been proven, and people will have no choice which one they get, a top government vaccine official told Reuters.
Karnataka readies to vaccinate Covid warriors
By IANS |
Published on
Fri, Jan 15 2021 20:51 IST |
0 Views
Karnataka readies to vaccinate Covid warriors . . Image Source: IANS News
Bengaluru, Jan 15 : All arrangements have been made to begin vaccinating 16-lakh Covid warriors at 243 centres across Karnataka from Saturday, said state Health Minister K. Sudhakar on Friday. Covishield vaccine will be administered at 237 centres and Covaxin at 6 centres across the state after Prime Minister Narendra Modi virtually unveils the drive in Bengaluru on Saturday from New Delhi through video-conferencing, Sudhakar told reporters here.
Arrangements for the drive include 10 walk-in coolers, 4 walk-in freezers, 3,210 ice lined refrigerators (ILRs), 46,591 vaccine carriers and 2,25,749 ice packs.